Circulating CD19+ blood cell levels in myeloma [4]

N. E. Kay; M. M. Oken; N. Bone; R. A. Kyle; P. Greipp; B. Van Ness; T. Leong; L. M. Pilarski

doi:10.1182/blood.v86.10.4000.bloodjournal86104000

Circulating CD19⁺ blood cell levels in myeloma [4]

N. E. Kay, M. M. Oken, N. Bone, R. A. Kyle, P. Greipp, B. Van Ness, T. Leong, L. M. Pilarski

Genetics, Cell Biology and Development (TMED)

Research output: Contribution to journal › Letter › peer-review

11 Scopus citations

Original language	English (US)
Pages (from-to)	4000-4001
Number of pages	2
Journal	Blood
Volume	86
Issue number	10
DOIs	https://doi.org/10.1182/blood.v86.10.4000.bloodjournal86104000
State	Published - 1995

Publisher link

10.1182/blood.v86.10.4000.bloodjournal86104000

Find It

Find It at U of M Libraries

Cite this

@article{524dc8e0c2a74fb3b02a115ea8585d40,

title = "Circulating CD19+ blood cell levels in myeloma [4]",

author = "Kay, {N. E.} and Oken, {M. M.} and N. Bone and Kyle, {R. A.} and P. Greipp and {Van Ness}, B. and T. Leong and Pilarski, {L. M.}",

year = "1995",

doi = "10.1182/blood.v86.10.4000.bloodjournal86104000",

language = "English (US)",

volume = "86",

pages = "4000--4001",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "10",

}

TY - JOUR

T1 - Circulating CD19+ blood cell levels in myeloma [4]

AU - Kay, N. E.

AU - Oken, M. M.

AU - Bone, N.

AU - Kyle, R. A.

AU - Greipp, P.

AU - Van Ness, B.

AU - Leong, T.

AU - Pilarski, L. M.

PY - 1995

Y1 - 1995

UR - http://www.scopus.com/inward/record.url?scp=0028810991&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028810991&partnerID=8YFLogxK

U2 - 10.1182/blood.v86.10.4000.bloodjournal86104000

DO - 10.1182/blood.v86.10.4000.bloodjournal86104000

M3 - Letter

C2 - 7579374

AN - SCOPUS:0028810991

SN - 0006-4971

VL - 86

SP - 4000

EP - 4001

JO - Blood

JF - Blood

IS - 10

ER -

Circulating CD19+ blood cell levels in myeloma [4]

Publisher link

Find It

Other files and links

Cite this

Circulating CD19⁺ blood cell levels in myeloma [4]